Dual targeting of CTLA-4 and CD47 on T _reg cells promotes immunity against solid tumors

Anli Zhang, Zhenhua Ren, Kuo‐Fu Tseng, +6

Science Translational Medicine

Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression

Yan Zhou, Ruihua Zhao, Kuo‐Fu Tseng, +8

Acta Pharmacologica Sinica

Tumor BiologyHuman Osteosarcoma CellsMedicineApoptosisImmunology +8

The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia

Lan Deng, Ling Jiang, Xianghua Lin, +6

Acta Pharmacologica Sinica

Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaMalignant Blood Disorder +8

The mitotic kinesin-14 KlpA contains a context-dependent directionality switch

Andrew R. Popchock, Kuo‐Fu Tseng, Pan Wang, +3

Nature Communications

BiologyPattern FormationProtein FunctionCell DivisionKlpa Motility +12

Redundant Mechanisms Recruit Actin into the Contractile Ring in Silkworm Spermatocytes

Wei Chen, Margit Foss, Kuo‐Fu Tseng, +1

PLoS Biology

EngineeringContractile RingCytoskeletonMechanotransductionReproductive Biology +19

Distinct kinesin motors drive two types of maize neocentromeres

Kyle W Swentowsky, Jonathan I. Gent, Elizabeth G. Lowry, +6

Genes & Development

A fluid membrane enhances the velocity of cargo transport by small teams of kinesin-1

Qiaochu Li, Kuo‐Fu Tseng, Stephen J. King, +2

The Journal of Chemical Physics

Single KinesinMolecular BiologyCytoskeletonCell BiophysicsCellular Physiology +18

The preprophase band-associated kinesin-14 OsKCH2 is a processive minus-end-directed microtubule motor

Kuo‐Fu Tseng, Pan Wang, Yuh‐Ru Julie Lee, +5

Nature Communications

Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell

Lin Lü, Yuan Shen, Kuo‐Fu Tseng, +3

Cancer Biomarkers

Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells

Lan Deng, Ling Jiang, Xianghua Lin, +3

Oncology Letters